欧州ガンマブチロラクトン市場-2030年までの産業動向と予測Europe Gamma Butyrolactone Market - Industry Trends and Forecast to 2030 欧州のガンマブチロラクトン市場は、2023年から2030年の予測期間に2.8%のCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年... もっと見る
サマリー欧州のガンマブチロラクトン市場は、2023年から2030年の予測期間に2.8%のCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です。市場細分化: 欧州γブチロラクトン市場:グレード別(工業用クラス(5重量%)、電気容量クラス(9重量%)、一般用クラス(8重量%))、純度(最低99.9%、最低99.7%)、用途(溶剤、鋳造用バインダー、除草剤・殺虫剤、電池・コンデンサ、塗料剥離剤、研磨剤、麻酔剤、鎮静剤、その他)、最終用途(医薬品、電機産業、農薬、石油産業、食品産業、その他)、国(U.K.イタリア、フランス、スペイン、ロシア、スイス、トルコ、ベルギー、ルクセンブルク、オランダ、その他ヨーロッパ)産業動向と2030年までの予測 欧州のガンマブチロラクトン市場の成長に寄与する主な要因の一部をご紹介します: - 有機農薬の需要拡大 - 飲料の清澄剤としての食品産業への応用 市場のプレーヤー: 欧州のガンマブチロラクトン市場で活動している主なプレイヤーは以下の通りです: - BASF SE - アシュランド - ボアイNKYファーマシューティカルズ株式会社 - 三菱化学株式会社 - バラジ・アミンズ 目次TABLE OF CONTENTS1 INTRODUCTION 21 1.1 OBJECTIVES OF THE STUDY 21 1.2 MARKET DEFINITION 21 1.3 OVERVIEW OF THE EUROPE GAMMA BUTYROLACTONE MARKET 21 1.4 LIMITATIONS 22 1.5 MARKETS COVERED 23 2 MARKET SEGMENTATION 26 2.1 MARKETS COVERED 26 2.2 GEOGRAPHICAL SCOPE 27 2.3 YEARS CONSIDERED FOR THE STUDY 28 2.4 CURRENCY AND PRICING 28 2.5 DBMR TRIPOD DATA VALIDATION MODEL 29 2.6 GRADE LIFE LINE CURVE 32 2.7 MULTIVARIATE MODELING 33 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34 2.9 DBMR MARKET POSITION GRID 35 2.10 MARKET END-USE COVERAGE GRID 36 2.11 DBMR MARKET CHALLENGE MATRIX 37 2.12 DBMR VENDOR SHARE ANALYSIS 38 2.13 IMPORT-EXPORT DATA 39 2.14 SECONDARY SOURCES 40 2.15 ASSUMPTIONS 41 3 EXECUTIVE SUMMARY 42 4 PREMIUM INSIGHTS 44 4.1 PESTLE ANALYSIS 45 4.1.1 POLITICAL FACTORS 45 4.1.2 ECONOMIC FACTORS 46 4.1.3 SOCIAL FACTORS 46 4.1.4 TECHNOLOGICAL FACTORS 46 4.1.5 LEGAL FACTORS 46 4.1.6 ENVIRONMENTAL FACTORS 46 4.2 PORTER'S FIVE FORCES: 47 4.2.1 THREAT OF NEW ENTRANTS: 47 4.2.2 THREAT OF SUBSTITUTES: 47 4.2.3 CUSTOMER BARGAINING POWER: 48 4.2.4 SUPPLIER BARGAINING POWER: 48 4.2.5 INTERNAL COMPETITION (RIVALRY): 48 4.3 CLIMATE CHANGE SCENARIO 49 4.3.1 ENVIRONMENTAL CONCERNS 49 4.3.2 INDUSTRY RESPONSE 49 4.3.3 GOVERNMENT'S ROLE 49 4.3.4 ANALYST RECOMMENDATION 49 4.4 LIST OF KEY PATENTS LAUNCHED 50 4.5 SUPPLY CHAIN ANALYSIS 51 4.5.1 OVERVIEW 51 4.5.2 LOGISTIC COST SCENARIO 51 4.5.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 52 4.6 VENDOR SELECTION CRITERIA 53 5 MARKET OVERVIEW 54 5.1 DRIVERS 56 5.1.1 GROWING APPLICATION OF DERIVED CHEMICAL PRODUCTS 56 5.1.2 APPLICATION IN A WIDE RANGE OF INDUSTRIES 56 5.1.3 INCREASED DEMAND FOR ELECTRONIC ITEMS 57 5.2 RESTRAINTS 58 5.2.1 SERIOUS HEALTH EFFECTS AND SAFETY CONCERNS 58 5.2.2 STRINGENT RULES AND REGULATIONS 58 5.3 OPPORTUNITIES 59 5.3.1 RISE IN DEMAND FOR ELECTRIC VEHICLES 59 5.3.2 INCREASE IN USAGE OF ORGANIC AGROCHEMICALS 59 5.4 CHALLENGES 60 5.4.1 GOVERNMENT RESTRICTIONS FOR ILLEGAL USAGE 60 6 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE 61 6.1 OVERVIEW 62 6.2 INDUSTRIAL CLASS (5 WT.%) 64 6.3 ELECTRIC CAPACITANCE CLASS (9 WT.%) 65 6.4 COMMON CLASS (8 WT.%) 66 7 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY 67 7.1 OVERVIEW 68 7.2 MIN. 99.9% 69 7.3 MIN. 99.7% 70 8 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION 71 8.1 OVERVIEW 72 8.2 SOLVENT 73 8.3 CASTING BINDER 74 8.4 HERBICIDES AND INSECTICIDES 74 8.5 BATTERIES AND CAPACITORS 75 8.6 PAINT STRIPPERS 76 8.7 POLISH REMOVERS 76 8.8 ANESTHETIC 77 8.9 SEDATIVE 78 8.10 OTHERS 79 9 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE 80 9.1 OVERVIEW 81 9.2 PHARMACEUTICAL INDUSTRY 82 9.3 ELECTRICAL INDUSTRY 83 9.4 AGROCHEMICAL INDUSTRY 84 9.5 PETROLEUM INDUSTRY 84 9.6 FOOD INDUSTRY 85 9.7 OTHERS 86 10 EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION 87 10.1 EUROPE 88 10.1.1 FRANCE 94 10.1.2 GERMANY 96 10.1.3 U.K. 98 10.1.4 ITALY 100 10.1.5 TURKEY 102 10.1.6 BELGIUM 104 10.1.7 SPAIN 106 10.1.8 RUSSIA 108 10.1.9 SWITZERLAND 110 10.1.10 NETHERLANDS 112 10.1.11 REST OF EUROPE 114 11 EUROPE GAMMA BUTYROLACTONE MARKET: COMPANY LANDSCAPE 115 11.1 COMPANY SHARE ANALYSIS: EUROPE 115 11.2 RECOGNITION 116 11.3 AWARD 116 11.4 EVENT 117 11.5 EXPANSION 117 11.6 AGREEMENT 117 12 SWOT ANALYSIS 118 13 COMPANY PROFILES 119 13.1 MITSUBISHI CHEMICAL CORPORATION. 119 13.1.1 COMPANY SNAPSHOT 119 13.1.2 REVENUE ANALYSIS 119 13.1.3 COMPANY SHARE ANALYSIS 120 13.1.4 PRODUCT PORTFOLIO 120 13.1.5 RECENT DEVELOPMENTS 120 13.2 BASF SE 121 13.2.1 COMPANY SNAPSHOT 121 13.2.2 REVENUE ANALYSIS 121 13.2.3 COMPANY SHARE ANALYSIS 122 13.2.4 PRODUCT PORTFOLIO 122 13.2.5 RECENT DEVELOPMENT 122 13.3 SIPCHEM COMPANY 123 13.3.1 COMPANY SNAPSHOT 123 13.3.2 REVENUE ANALYSIS 123 13.3.3 COMPANY SHARE ANALYSIS 124 13.3.4 PRODUCT PORTFOLIO 124 13.3.5 RECENT DEVELOPMENTS 124 13.4 BALAJI AMINES 126 13.4.1 COMPANY SNAPSHOT 126 13.4.2 REVENUE ANALYSIS 126 13.4.3 COMPANY SHARE ANALYSIS 127 13.4.4 PRODUCT PORTFOLIO 127 13.4.5 RECENT DEVELOPMENTS 127 13.5 ASHLAND 128 13.5.1 COMPANY SNAPSHOT 128 13.5.2 REVENUE ANALYSIS 128 13.5.3 COMPANY SHARE ANALYSIS 129 13.5.4 PRODUCT PORTFOLIO 129 13.5.5 RECENT DEVELOPMENT 129 13.6 BIOSYNTH 130 13.6.1 COMPANY SNAPSHOT 130 13.6.2 PRODUCT PORTFOLIO 130 13.6.3 RECENT DEVELOPMENT 130 13.7 BOAI NKY PHARMACEUTICALS LTD. 131 13.7.1 COMPANY SNAPSHOT 131 13.7.2 PRODUCT PORTFOLIO 131 13.7.3 RECENT DEVELOPMENT 131 13.8 BYN CHEMICALS CO., LTD 132 13.8.1 COMPANY SNAPSHOT 132 13.8.2 PRODUCT PORTFOLIO 132 13.8.3 RECENT DEVELOPMENT 132 13.9 DCC 133 13.9.1 COMPANY SNAPSHOT 133 13.9.2 PRODUCT PORTFOLIO 133 13.9.3 RECENT DEVELOPMENT 134 13.10 ZHEJIANG REALSUN CHEMICAL CO.,LTD. 135 13.10.1 COMPANY SNAPSHOT 135 13.10.2 PRODUCT PORTFOLIO 135 13.10.3 RECENT DEVELOPMENTS 135 14 QUESTIONNAIRE 136 15 RELATED REPORTS 139 図表リストLIST OF TABLESTABLE 1 IMPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND) 33 TABLE 2 EXPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND) 33 TABLE 3 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 57 TABLE 4 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 57 TABLE 5 EUROPE INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 58 TABLE 6 EUROPE INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 58 TABLE 7 EUROPE ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 59 TABLE 8 EUROPE ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 59 TABLE 9 EUROPE COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 60 TABLE 10 EUROPE COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 60 TABLE 11 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 63 TABLE 12 EUROPE MIN. 99.9% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 63 TABLE 13 EUROPE MIN. 99.7% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 64 TABLE 14 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 67 TABLE 15 EUROPE SOLVENT IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 67 TABLE 16 EUROPE CASTING BINDER IN EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 68 TABLE 17 EUROPE HERBICIDES AND INSECTICIDES IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 69 TABLE 18 EUROPE BATTERIES AND CAPACITORS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 69 TABLE 19 EUROPE PAINT STRIPPERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 70 TABLE 20 EUROPE POLISH REMOVERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 71 TABLE 21 EUROPE ANESTHETIC IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 71 TABLE 22 EUROPE SEDATIVE IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 72 TABLE 23 EUROPE OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 73 TABLE 24 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 76 TABLE 25 EUROPE PHARMACEUTICAL INDUSTRY IN EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 76 TABLE 26 EUROPE ELECTRICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 77 TABLE 27 EUROPE AGROCHEMICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 78 TABLE 28 EUROPE PETROLEUM INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 79 TABLE 29 EUROPE FOOD INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 79 TABLE 30 EUROPE OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 80 TABLE 31 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (USD THOUSAND) 85 TABLE 32 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (TONS) 85 TABLE 33 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 86 TABLE 34 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 86 TABLE 35 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 86 TABLE 36 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 87 TABLE 37 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 87 TABLE 38 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 88 TABLE 39 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 88 TABLE 40 FRANCE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 88 TABLE 41 FRANCE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 89 TABLE 42 FRANCE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 89 TABLE 43 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 90 TABLE 44 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 90 TABLE 45 GERMANY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 90 TABLE 46 GERMANY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 91 TABLE 47 GERMANY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 91 TABLE 48 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 92 TABLE 49 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 92 TABLE 50 U.K. GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 92 TABLE 51 U.K. GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 93 TABLE 52 U.K. GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 93 TABLE 53 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 94 TABLE 54 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 94 TABLE 55 ITALY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 94 TABLE 56 ITALY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 95 TABLE 57 ITALY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 95 TABLE 58 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 96 TABLE 59 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 96 TABLE 60 TURKEY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 96 TABLE 61 TURKEY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 97 TABLE 62 TURKEY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 97 TABLE 63 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 98 TABLE 64 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 98 TABLE 65 BELGIUM GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 98 TABLE 66 BELGIUM GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 99 TABLE 67 BELGIUM GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 99 TABLE 68 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 100 TABLE 69 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 100 TABLE 70 SPAIN GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 100 TABLE 71 SPAIN GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 101 TABLE 72 SPAIN GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 101 TABLE 73 RUSSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 102 TABLE 74 RUSSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 102 TABLE 75 RUSSIA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 102 TABLE 76 RUSSIA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 103 TABLE 77 RUSSIA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 103 TABLE 78 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 104 TABLE 79 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 104 TABLE 80 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 104 TABLE 81 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 105 TABLE 82 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 105 TABLE 83 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 106 TABLE 84 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 106 TABLE 85 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 106 TABLE 86 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 107 TABLE 87 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 107 TABLE 88 REST OF EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 108 TABLE 89 REST OF EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 108
SummaryEurope gamma butyrolactone market is projected to register a 2.8% CAGR in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 21 1.1 OBJECTIVES OF THE STUDY 21 1.2 MARKET DEFINITION 21 1.3 OVERVIEW OF THE EUROPE GAMMA BUTYROLACTONE MARKET 21 1.4 LIMITATIONS 22 1.5 MARKETS COVERED 23 2 MARKET SEGMENTATION 26 2.1 MARKETS COVERED 26 2.2 GEOGRAPHICAL SCOPE 27 2.3 YEARS CONSIDERED FOR THE STUDY 28 2.4 CURRENCY AND PRICING 28 2.5 DBMR TRIPOD DATA VALIDATION MODEL 29 2.6 GRADE LIFE LINE CURVE 32 2.7 MULTIVARIATE MODELING 33 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34 2.9 DBMR MARKET POSITION GRID 35 2.10 MARKET END-USE COVERAGE GRID 36 2.11 DBMR MARKET CHALLENGE MATRIX 37 2.12 DBMR VENDOR SHARE ANALYSIS 38 2.13 IMPORT-EXPORT DATA 39 2.14 SECONDARY SOURCES 40 2.15 ASSUMPTIONS 41 3 EXECUTIVE SUMMARY 42 4 PREMIUM INSIGHTS 44 4.1 PESTLE ANALYSIS 45 4.1.1 POLITICAL FACTORS 45 4.1.2 ECONOMIC FACTORS 46 4.1.3 SOCIAL FACTORS 46 4.1.4 TECHNOLOGICAL FACTORS 46 4.1.5 LEGAL FACTORS 46 4.1.6 ENVIRONMENTAL FACTORS 46 4.2 PORTER'S FIVE FORCES: 47 4.2.1 THREAT OF NEW ENTRANTS: 47 4.2.2 THREAT OF SUBSTITUTES: 47 4.2.3 CUSTOMER BARGAINING POWER: 48 4.2.4 SUPPLIER BARGAINING POWER: 48 4.2.5 INTERNAL COMPETITION (RIVALRY): 48 4.3 CLIMATE CHANGE SCENARIO 49 4.3.1 ENVIRONMENTAL CONCERNS 49 4.3.2 INDUSTRY RESPONSE 49 4.3.3 GOVERNMENT'S ROLE 49 4.3.4 ANALYST RECOMMENDATION 49 4.4 LIST OF KEY PATENTS LAUNCHED 50 4.5 SUPPLY CHAIN ANALYSIS 51 4.5.1 OVERVIEW 51 4.5.2 LOGISTIC COST SCENARIO 51 4.5.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 52 4.6 VENDOR SELECTION CRITERIA 53 5 MARKET OVERVIEW 54 5.1 DRIVERS 56 5.1.1 GROWING APPLICATION OF DERIVED CHEMICAL PRODUCTS 56 5.1.2 APPLICATION IN A WIDE RANGE OF INDUSTRIES 56 5.1.3 INCREASED DEMAND FOR ELECTRONIC ITEMS 57 5.2 RESTRAINTS 58 5.2.1 SERIOUS HEALTH EFFECTS AND SAFETY CONCERNS 58 5.2.2 STRINGENT RULES AND REGULATIONS 58 5.3 OPPORTUNITIES 59 5.3.1 RISE IN DEMAND FOR ELECTRIC VEHICLES 59 5.3.2 INCREASE IN USAGE OF ORGANIC AGROCHEMICALS 59 5.4 CHALLENGES 60 5.4.1 GOVERNMENT RESTRICTIONS FOR ILLEGAL USAGE 60 6 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE 61 6.1 OVERVIEW 62 6.2 INDUSTRIAL CLASS (5 WT.%) 64 6.3 ELECTRIC CAPACITANCE CLASS (9 WT.%) 65 6.4 COMMON CLASS (8 WT.%) 66 7 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY 67 7.1 OVERVIEW 68 7.2 MIN. 99.9% 69 7.3 MIN. 99.7% 70 8 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION 71 8.1 OVERVIEW 72 8.2 SOLVENT 73 8.3 CASTING BINDER 74 8.4 HERBICIDES AND INSECTICIDES 74 8.5 BATTERIES AND CAPACITORS 75 8.6 PAINT STRIPPERS 76 8.7 POLISH REMOVERS 76 8.8 ANESTHETIC 77 8.9 SEDATIVE 78 8.10 OTHERS 79 9 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE 80 9.1 OVERVIEW 81 9.2 PHARMACEUTICAL INDUSTRY 82 9.3 ELECTRICAL INDUSTRY 83 9.4 AGROCHEMICAL INDUSTRY 84 9.5 PETROLEUM INDUSTRY 84 9.6 FOOD INDUSTRY 85 9.7 OTHERS 86 10 EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION 87 10.1 EUROPE 88 10.1.1 FRANCE 94 10.1.2 GERMANY 96 10.1.3 U.K. 98 10.1.4 ITALY 100 10.1.5 TURKEY 102 10.1.6 BELGIUM 104 10.1.7 SPAIN 106 10.1.8 RUSSIA 108 10.1.9 SWITZERLAND 110 10.1.10 NETHERLANDS 112 10.1.11 REST OF EUROPE 114 11 EUROPE GAMMA BUTYROLACTONE MARKET: COMPANY LANDSCAPE 115 11.1 COMPANY SHARE ANALYSIS: EUROPE 115 11.2 RECOGNITION 116 11.3 AWARD 116 11.4 EVENT 117 11.5 EXPANSION 117 11.6 AGREEMENT 117 12 SWOT ANALYSIS 118 13 COMPANY PROFILES 119 13.1 MITSUBISHI CHEMICAL CORPORATION. 119 13.1.1 COMPANY SNAPSHOT 119 13.1.2 REVENUE ANALYSIS 119 13.1.3 COMPANY SHARE ANALYSIS 120 13.1.4 PRODUCT PORTFOLIO 120 13.1.5 RECENT DEVELOPMENTS 120 13.2 BASF SE 121 13.2.1 COMPANY SNAPSHOT 121 13.2.2 REVENUE ANALYSIS 121 13.2.3 COMPANY SHARE ANALYSIS 122 13.2.4 PRODUCT PORTFOLIO 122 13.2.5 RECENT DEVELOPMENT 122 13.3 SIPCHEM COMPANY 123 13.3.1 COMPANY SNAPSHOT 123 13.3.2 REVENUE ANALYSIS 123 13.3.3 COMPANY SHARE ANALYSIS 124 13.3.4 PRODUCT PORTFOLIO 124 13.3.5 RECENT DEVELOPMENTS 124 13.4 BALAJI AMINES 126 13.4.1 COMPANY SNAPSHOT 126 13.4.2 REVENUE ANALYSIS 126 13.4.3 COMPANY SHARE ANALYSIS 127 13.4.4 PRODUCT PORTFOLIO 127 13.4.5 RECENT DEVELOPMENTS 127 13.5 ASHLAND 128 13.5.1 COMPANY SNAPSHOT 128 13.5.2 REVENUE ANALYSIS 128 13.5.3 COMPANY SHARE ANALYSIS 129 13.5.4 PRODUCT PORTFOLIO 129 13.5.5 RECENT DEVELOPMENT 129 13.6 BIOSYNTH 130 13.6.1 COMPANY SNAPSHOT 130 13.6.2 PRODUCT PORTFOLIO 130 13.6.3 RECENT DEVELOPMENT 130 13.7 BOAI NKY PHARMACEUTICALS LTD. 131 13.7.1 COMPANY SNAPSHOT 131 13.7.2 PRODUCT PORTFOLIO 131 13.7.3 RECENT DEVELOPMENT 131 13.8 BYN CHEMICALS CO., LTD 132 13.8.1 COMPANY SNAPSHOT 132 13.8.2 PRODUCT PORTFOLIO 132 13.8.3 RECENT DEVELOPMENT 132 13.9 DCC 133 13.9.1 COMPANY SNAPSHOT 133 13.9.2 PRODUCT PORTFOLIO 133 13.9.3 RECENT DEVELOPMENT 134 13.10 ZHEJIANG REALSUN CHEMICAL CO.,LTD. 135 13.10.1 COMPANY SNAPSHOT 135 13.10.2 PRODUCT PORTFOLIO 135 13.10.3 RECENT DEVELOPMENTS 135 14 QUESTIONNAIRE 136 15 RELATED REPORTS 139 List of Tables/GraphsLIST OF TABLESTABLE 1 IMPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND) 33 TABLE 2 EXPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND) 33 TABLE 3 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 57 TABLE 4 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 57 TABLE 5 EUROPE INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 58 TABLE 6 EUROPE INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 58 TABLE 7 EUROPE ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 59 TABLE 8 EUROPE ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 59 TABLE 9 EUROPE COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 60 TABLE 10 EUROPE COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS) 60 TABLE 11 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 63 TABLE 12 EUROPE MIN. 99.9% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 63 TABLE 13 EUROPE MIN. 99.7% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 64 TABLE 14 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 67 TABLE 15 EUROPE SOLVENT IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 67 TABLE 16 EUROPE CASTING BINDER IN EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 68 TABLE 17 EUROPE HERBICIDES AND INSECTICIDES IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 69 TABLE 18 EUROPE BATTERIES AND CAPACITORS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 69 TABLE 19 EUROPE PAINT STRIPPERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 70 TABLE 20 EUROPE POLISH REMOVERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 71 TABLE 21 EUROPE ANESTHETIC IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 71 TABLE 22 EUROPE SEDATIVE IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 72 TABLE 23 EUROPE OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 73 TABLE 24 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 76 TABLE 25 EUROPE PHARMACEUTICAL INDUSTRY IN EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 76 TABLE 26 EUROPE ELECTRICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 77 TABLE 27 EUROPE AGROCHEMICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 78 TABLE 28 EUROPE PETROLEUM INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 79 TABLE 29 EUROPE FOOD INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 79 TABLE 30 EUROPE OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND) 80 TABLE 31 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (USD THOUSAND) 85 TABLE 32 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (TONS) 85 TABLE 33 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 86 TABLE 34 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 86 TABLE 35 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 86 TABLE 36 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 87 TABLE 37 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 87 TABLE 38 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 88 TABLE 39 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 88 TABLE 40 FRANCE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 88 TABLE 41 FRANCE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 89 TABLE 42 FRANCE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 89 TABLE 43 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 90 TABLE 44 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 90 TABLE 45 GERMANY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 90 TABLE 46 GERMANY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 91 TABLE 47 GERMANY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 91 TABLE 48 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 92 TABLE 49 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 92 TABLE 50 U.K. GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 92 TABLE 51 U.K. GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 93 TABLE 52 U.K. GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 93 TABLE 53 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 94 TABLE 54 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 94 TABLE 55 ITALY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 94 TABLE 56 ITALY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 95 TABLE 57 ITALY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 95 TABLE 58 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 96 TABLE 59 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 96 TABLE 60 TURKEY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 96 TABLE 61 TURKEY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 97 TABLE 62 TURKEY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 97 TABLE 63 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 98 TABLE 64 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 98 TABLE 65 BELGIUM GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 98 TABLE 66 BELGIUM GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 99 TABLE 67 BELGIUM GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 99 TABLE 68 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 100 TABLE 69 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 100 TABLE 70 SPAIN GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 100 TABLE 71 SPAIN GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 101 TABLE 72 SPAIN GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 101 TABLE 73 RUSSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 102 TABLE 74 RUSSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 102 TABLE 75 RUSSIA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 102 TABLE 76 RUSSIA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 103 TABLE 77 RUSSIA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 103 TABLE 78 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 104 TABLE 79 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 104 TABLE 80 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 104 TABLE 81 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 105 TABLE 82 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 105 TABLE 83 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 106 TABLE 84 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 106 TABLE 85 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND) 106 TABLE 86 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND) 107 TABLE 87 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND) 107 TABLE 88 REST OF EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND) 108 TABLE 89 REST OF EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS) 108
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(ケミカル)の最新刊レポートData Bridge Market Research社のケミカル・素材分野での最新刊レポート
本レポートと同じKEY WORD(industry)の最新刊レポートよくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |